STEFAN J. CROSS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Inhibitor Therapeutics, Inc.

Filing Date Source Excerpt
2017-11-13 Stefan J. Cross, age 44, is a director of our Company and the appointee of Mayne Pharma to our Board. ... Mr. Cross is qualified to serve on our Board because of his extensive business experience in the pharmaceutical industry.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25